Jessika L. Roser, PA-C

Jessika Roser practices at Baycare Medical Group, Inc. in Saint Petersburg, Florida.

Jessika Roser's NPI, 1033574165, was assigned on December 16, 2015.

Jessika Roser's primary practice is Baycare Medical Group, Inc., at 620 10th N St, Saint Petersburg, FL 33705 in Pinellas County. The practice phone is (727) 281-9065.

Jessika Roser's primary practice is Baycare Medical Group, Inc. in Saint Petersburg, Florida. Jessika Roser is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is BayCare Medical Group. Dmand AI also links Jessika Roser to 1 more group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jessika Roser practices, 3 sites in all. Vendor and product names are available with a free account.

Medical is Jessika Roser's primary specialty in the NPI Registry, under taxonomy code 363AM0700X.

CMS data shows 184 Medicare services from Jessika Roser across 4 procedure codes in 2024, for 110 Medicare patients. Medicare paid $13,278 for them. Every service was in an office.

CMS counts 110 Medicare patients who saw Jessika Roser in 2024. The largest group is 65 to 74, with 72 patients. 69% of them have high blood pressure, and 67% have high cholesterol. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Jessika Roser's median patient age at 45, with 71% women.

In 2024, Jessika Roser wrote 1,191 Medicare Part D claims for 159 patients. 89% of them were for generic drugs. CMS names the drug for 751 of them, across 32 drugs with 11 or more claims each, at $22,436 in total drug cost.

Jessika Roser accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Jessika Roser as offering telehealth.

CMS Open Payments shows 60 general payments to Jessika Roser from 15 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $295.